Continuous development and commercialisation of proprietary products and increasing the new-product ratio
First written in FY2017. 4 of 8 entries say "Advanced", first in FY2020. Latest entry: FY2026.
26 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「We are developing bio-based plasticizers (TBIO+), which have received positive evaluations from many customers. Bio-based plasticizer (TBIO+) received the 76th Industrial Technology Award from the Osaka Association for Industrial Technology.」
In addition to positive customer evaluations of its bio-based plasticizer, the company received specific external recognition in the form of the Industrial Technology Award. It is also advancing the development of new manufacturing processes for resin monomers for optical lenses, chemical recycling, and scintillator materials. - FY2024AdvancedAnnual report
「For graphene nanoribbons, in addition to developing a mass-production process and applying it to similar carbon-based materials, we obtained the Nanopapillon trademark and began selling the product as a reagent.」
For graphene nanoribbons, concrete progress toward commercialisation was demonstrated through the development of a mass-production process, trademark registration and the start of reagent sales. - FY2023AdvancedAnnual report
「For graphene nanoribbons, we are developing a mass-production process and applying the technology to similar carbon-based materials, and have begun providing samples to other companies.」
Concrete progress in new product development was demonstrated through the development of a new manufacturing process for resin monomers for optical lenses, the development of a mass-production process for graphene nanoribbons, and the start of sample provision to other companies. - FY2022RaisedAnnual report
「New product development target: ¥7.0 billion per year」
In addition to the ongoing target of maintaining a new-product ratio of at least 20%, the new medium-term plan sets new product development of ¥7.0 billion per year as a KPI. - FY2021RestatedAnnual report
「Strengthening overall R&D capabilities and increasing the new-product commercialisation ratio through the continuous development and commercialisation of proprietary products」
Strengthening R&D capabilities, developing and commercialising proprietary products, and increasing the new-product commercialisation ratio continue as measures under the medium-term management plan. - FY2020AdvancedAnnual report
「We achieved a new-product ratio of at least 20%, making a good start in the first year of the medium-term plan.」
In fiscal 2019, the first year of the medium-term plan, we achieved a new-product ratio of at least 20%. - FY2018RestatedAnnual report
「Strengthening overall R&D capabilities and increasing the new-product ratio through the continuous development and commercialisation of proprietary products」
We continue to pursue an R&D policy that includes developing and commercialising proprietary products and increasing the new-product ratio. No specific product commercialisation achievement was disclosed for the current fiscal year. - FY2017First statedAnnual report
「Strengthening overall R&D capabilities and increasing the new-product ratio through the continuous development and commercialisation of proprietary products」
As measures under the medium-term management plan, we aim to strengthen R&D capabilities, develop and commercialise proprietary products, and increase the new-product ratio.